Board of Trustees

Gary E. Lemack, MD

Gary E. Lemack, MD

PRESIDENT

Dr. Lemack is Professor of Urology at The University of Texas Southwestern Medical Center, and Director of the Residency Program. He has a secondary appointment in the Department of Neurology. He is Board certified in Urology and Female Pelvic Medicine and Reconstructive Surgery. After graduating from Cornell University Medical College, he completed his urologic residency at The New York Hospital – Cornell Medical Center, and then a 2-year fellowship in FPMRS/Neurourology at UT Southwestern, where he has been on the faculty since 1999. His clinical practice focuses on care for patient with voiding disorders in the setting of neurological disease, as well as women with incontinence, pelvic organ prolapse and other refractory bladder disorders. His clinical research has focused on improving incontinence care for men and women with neurological conditions such as multiple sclerosis and spinal cord injury. Much of his work has involved collaborations with the NIH/ NIDDK-sponsored Urinary Incontinence Treatment Network. He currently has authored or co-authored over 140 peer-reviewed publications and over 20 book chapters.

Dr. Lemack has served on the editorial board for the Journal of Urology and is an expert reviewer for over 10 Urology journals. He currently sits on the Editorial Board for Urology Practice. He is a Past President for the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU), and is Secretary/Treasurer, and Chairman of the Certifying Examination for the American Board of Urology. He is married, has three children and has lived in Plano Texas for over 20 years.

Martha K. Terris, MD

Martha K. Terris, MD

VICE PRESIDENT
Dr. Terris received her general surgery training at Duke University and urologic surgery training at Stanford University. Her urologic oncology fellowship training, also at Stanford, focused on prostate cancer diagnosis and staging. After completion of her training, she remained at Stanford as faculty member in the Department of Urology and Chief of Urology at the Palo Alto Veterans Affairs Medical Center where she was successful in accrual funding, mentoring resident/student research, published extensively, participated in numerous clinical trials, and maintained a busy clinical practice. Dr. Terris joined the faculty at AU and the Augusta Veterans Affairs Medical Center in 2002. She was named 2003-2004 Georgia Cancer Coalition Distinguished Cancer Scholar. Dr. Terris assumed the position of Program Director for the Urology Residency Training Program in 2003, Chief of Urology and has past served as president of the Society of Urology Chairs and Program Directors and a member of the Residency Review Committee for Urology. She has been repeatedly named to Top Doctors in America and America’s Best Doctors.
J. Stuart Wolf, Jr, MD

J. Stuart Wolf, Jr, MD

PRESIDENT-ELECT
Dr. Wolf has served on the Boards of Directors of the Michigan Urologic Society, the Endourological Society, and the Society of Academic Urologists. He currently sits on the Board of Directors of the Texas Urological Society. He chaired the American Urological Association (AUA) Practice Guidelines Committee, and was the inaugural chair of the AUA Science & Quality Council.  At the University of Michigan, Dr. Wolf received the Silver Cystoscope Award for Urology Residency Teaching Excellence 3 times (1999, 2002 and 2005). He was appointed the inaugural David A. Bloom Professor of Urology in 2006. The Department of Urology awarded him the Faculty Service Award in 2011 and the Outstanding Achievement Award in 2012. He was inducted into the League of Educational Excellence of the University of Michigan Medical School in 2015, and that year he also received the inaugural Program Director’s Award from the Endourological Society and was the Malcolm Coptcoat Lecturer for The British Association of Urologic Surgeons. In 2010, Dr. Wolf was elected to the American Association of Genitourinary Surgeons. In 2018, he started a 6-year term as a Trustee of the American Board of Urology. In 2019, Dr. Wolf received a Distinguished Service Award from the AUA.

An author of over 325 peer-reviewed articles and videos, and over 175 invited publications, Dr. Wolf has served on the editorial boards of 12 journals. His scholarly work has been recognized by awards and/or research grants from the American Foundation for Urologic Disease, the Department of Veterans Affairs, the Endourological Society, the American Society of Transplant Surgeons, and the AUA and 2 of its Sections.

James M McKiernan, MD

James M McKiernan, MD

SECRETARY-TREASURER

James McKiernan, MD, the John K. Lattimer Professor of Urology, is the chair of the Department of Urology of the College of Physicians and Surgeons and urologist-in-chief at New York-Presbyterian/Columbia. Dr. McKiernan is only the sixth physician to hold this title since the founding of the department in 1917. The Department of Urology, one of the oldest and most distinguished in the nation, consistently ranks among the top in New York and throughout the United States. New York-Presbyterian's urology program ranked No. 5 in the latest U.S. News & World Report ranking of America's best hospitals. In 2015, the department ranked No. 7 in NIH grant funding among academic Urology departments in America.

Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at New York-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused in urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.

For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Christopher L. Amling, MD

Christopher L. Amling, MD

TRUSTEE

Dr. Christopher L. Amling, FACS, is the John Barry Professor and Chair of the Department of Urology at Oregon Health & Science University (OHSU) where he also serves as Director of Robotic Surgery. He received his undergraduate education from the University of Oregon and his medical degree from OHSU. He did his surgery and urology residency training at Duke University Medical Center and then completed a fellowship in urologic oncology at the Mayo Clinic. Dr. Amling served in the US Navy for 20 years, attaining the rank of Captain. Before coming to OHSU in 2009, he was Program Director and Chair of Urology at the Naval Medical Center in San Diego and then Chief of the Division of Urology at the University of Alabama at Birmingham.

Dr. Amling has a longtime interest in resident training and experience in the development and assessment of resident evaluation tools. In collaboration with the ACGME, he developed the SECR resident competency evaluation system in 2001 which was made available via the ACGME website to program directors of all specialties. He served on the Urology Residency Review Committee (RRC) for six years and has been a member of other national committees related to resident education including the ACGME Urology Milestones Project Committee and the ACGME Advisory Committee on Education Outcome Assessment. Dr. Amling was Chair of the Fellowship Committee for the Society of Urologic Oncology and also served as President of the Society of University Urologists in 2009.

Dr. Amling has been on several national AUA committees including the Education Council, Research Council and the Public Media Committee, and is the recipient of the AUA Gold Cystoscope Award in 2009. He has served on the Board of Directors for both the WSAUA and SESAUA, and currently serves as President-Elect of the WSAUA. He is a member of multiple professional organizations including the American Surgical Association (ASA), the Western Urologic Forum (WUF), the American Association of Genitourinary Surgeons (AAGUS) and the Clinical Society of Genitourinary Surgeons (CSGUS). Dr. Amling has contributed over 215 peer-reviewed publications, many of which have focused on prostate cancer risk assessment and treatment outcomes. His clinical practice focuses on the utilization of robotic and minimally invasive surgery for the treatment of genitourinary malignancies.

David B. Bock, MD

David B. Bock, MD

TRUSTEE

Dr. Bock has been practicing urology in Kansas City since completing his training at the Mayo Clinic in 1991. He has special interest and expertise in the diagnosis and treatment of benign prostatic enlargement, kidney stone disease, male and female urinary incontinence, and cancers of the urinary tract. Additionally, Dr. Bock has extensive experience in the field of endoscopic urologic surgery.

Dr. Bock is actively involved in a number of clinical studies in many areas of urology. He serves as principal investigator in the majority of these studies.

Dr. Bock is certified by the American Board of Urology and is licensed in both Missouri and Kansas. He is a member of the American Urological Association, the American Association of Clinical Urologists, Metropolitan Medical Society, the South Central Section of the American Urological Association, and the Kansas City Urological Society.

Mark P. Cain, MD

Mark P. Cain, MD

TRUSTEE

Dr. Cain is a Professor of Urology in the Department of Urology, University of Washington School of Medicine.  He is Co-Chief of the Division of Urology, Director of Regional Surgical Services, and Director of Surgical Ambulatory Care for Seattle Children’s Hospital. 

Dr. Cain graduated from medical school at Oregon Health Sciences University in 1987.  He completed his residency in urology at Albany Medical Center, followed by a two-year fellowship in pediatric urology at the Mayo Clinic. 

He was a member of the urology faculty at Georgetown University for two years, then spent the next 23 years at Riley Hospital for Children and the Indiana University Department of Urology.  He served as the Robert Garrett Professor of Urology and Chief of Pediatric Urology until moving to Seattle in 2019.  His primary clinical interests are surgical reconstruction of congenital anomalies of the genitalia, complex lower urinary tract reconstruction, management of prenatal urologic abnormalities, and surgical management of urinary tract obstruction. Dr. Cain has published over 290 articles and book chapters regarding various topics in pediatric urology, but with a focus on both long-term and patient centered outcomes of urologic reconstruction.  He has been an invited lecturer and Visiting Professor internationally in multiple countries throughout North America, Europe, India, Africa, South America and Asia.

Dr. Cain has served on the Examination Committee for the ABU for several years, most recently as chair of the Pediatric Urology Exam Committee and is an Oral Exam Committee member.  He recently served as the Assistant Editor for Pediatric Urology for the Journal of Urology. He is a past member of the Executive Committee of the Society for Pediatric Urology and Section on Urology of the AAP, and Past Chair for the Section on Urology of the American Academy of Pediatrics. He is Past-President and Executive Committee member of the Society for Fetal Urology. 

Dr. Cain is a native of the Pacific Northwest, and he enjoys the many fruits of the area including hiking mountains in the high Cascades, fly fishing on remote streams with his family, and Willamette Valley Pinot Noir.  He is married to Charla Cain, has three adult children; Chelsea (Cain) Maclin, Alexandra (Cain) Wildeson, and James Cain, and a grandson Quinn Maclin-Cain.

Christopher M. Gonzalez, MD

Christopher M. Gonzalez, MD

TRUSTEE

Chris M. Gonzalez, MD, MBA, FACS is a native of Toledo, Ohio.  He graduated from Denison University in Granville, Ohio with a BS degree in 1989. Afterwards he obtained his MD degree from the University of Iowa College of Medicine in Iowa City, Iowa.  Dr. Gonzalez then completed both his general surgical and urologic residency training at the McGaw Medical Center, Northwestern University in Chicago, Illinois. Dr. Gonzalez served in the US Army National Guard from January 1991 – January 2001. He joined the Northwestern University Department of Urology in 2000 following residency, and was appointed Professor of Urology in 2011. He served as Chief of Urology for the VA Lakeside from 2003 – 2006 and completed his MBA degree from the Northwestern Kellogg School of Management in 2006.  He was the Director of Surgery for the Northwestern Medicine Surgical Services Department from 2014 - 2015. Dr. Gonzalez was the Lester Persky Professor and Chair of the Urology Institute at University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio from 2015 to 2018. He is currently the Albert J. Jr. and Claire Speh Professor and Chair of Urology for the Loyola University Medical Center and Stritch School of Medicine in August 2018.  Dr. Gonzalez was named the Chief of Surgery for the Loyola University Medical Center in September 2021.

He is the Associate Editor for the Genitourinary Reconstruction Section of Urology, section editor for the “Hands On” section of Urology Times, and Section Editor for the Urology Practice journal. He has served on the Board of Directors for the Genitourinary Reconstructive Surgery Society, and he was a member of the first International Consultation on Urologic Stricture Disease, and the first Urethral Stricture guidelines panel for the American Urological Association (AUA).

Dr. Gonzalez served as the Chair for the AUA Public Policy and Practice Management from 2016-2020. Previous to this position he served as Vice Chairman of the AUA Quality Improvement and patient Safety Committee and Public Policy and Practice Management. He is a former AUA Gallagher Health Care Policy Scholar and was a member of the second AUA Leadership program class.  Dr. Gonzalez has served on the AUA BPH Guidelines Committee, AUA expert panel to the AMA RUC, and he is now a senior editor on the ABU Examination Committee.  He was the President of the Chicago Urological Society in 2014.  Dr. Gonzalez is a member of the American Association of Genitourinary Surgeons.

Dr. Gonzalez has published over 150 peer reveiwed manuscripts, review articles, invited editorials, and book chapters.  He has had funded research in the past with a NIH pilot project in the area of prostate cancer screening in underserved populations, and an ambulatory care process improvement award from the Grant Healthcare Foundation.  His recent focus has been on patient reported outcome measures in the area of genitourinary reconstruction, practice patterns in reconstructive urologic surgery, practice integration of advanced practice providers, and the urology workforce shortage in the United States. His areas of clinical specialty include urethral stricture disease, salvage of failed hypospadias surgery, genitourinary fistula disease, erectile dysfunction, penile prosthetic placement, Peyronie’s disease, and penile curvature correction.

E. Ann Gormley, MD

E. Ann Gormley, MD

TRUSTEE

Dr. Gormley is a Professor of Surgery (Urology) at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. She received a BA in English and her medical degree at the University of Saskatchewan. While completing her residency in Urology at the University of Alberta, she earned an MSc in Experimental Surgery. She then completed a fellowship in Female Urology and Voiding Dysfunction.  Dr. Gormley is a member of the Royal College of Physicians and Surgeons of Canada and is Board Certified by the American Board of Urology with sub-certification in Female Pelvic Medicine and Reconstructive Surgery.

Dr. Gormley’ s interests are in female urology, voiding dysfunction and resident education. She was the Program Director for the Urology Program at Dartmouth-Hitchcock from 2001-2020 and now serves as the Associate Program Director. Dr. Gormley was awarded the ACGME “Courage to Teach” Award and is a member of the Geisel Academy of Master Educators.  She is a member of the Appointments, Promotions and Titles Committee for the Geisel School of Medicine at Dartmouth.  

Dr. Gormley was the Chairman of the NIDDK’s Urinary Incontinence Network and is a Past President of the Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).  She is a Past President of the Society of Urology Chairmen and Program Directors (SUCPD).   Dr. Gormley served on the AUA/ABU Exam Committee as a member and consultant and is an oral board examiner for the American Board of Urology. She was on the ACGME Urology Residency Review Committee.  Dr. Gormley previously served on the AUA Stress Incontinence Guidelines Committee and Chaired the AUA Overactive Guidelines Panel.  She is a former Assistant Editor for the Journal of Urology and Urology Practice. She is the Assistant Editor for AUA Updates.    Dr. Gormley is a member of the American Association of Genitourinary Surgeons.

Dr. Gormley is an Associate Member of the Committee on Certification for the American Board of Medical Specialties.  A Past President and former Secretary for the New England Section of the AUA, Dr. Gormley currently serves as the New England Section’s representative to the Board of the American Urologic Association.
Christopher J. Kane, MD

Christopher J. Kane, MD

TRUSTEE

Dean of Clinical Affairs; Chief Executive Officer of UC San Diego Health Physician Group; Professor, Department of Urology, UC San Diego Health. Dr. Kane leads the clinical environment at UC San Diego Health including the sixty-five ambulatory clinics and the professional practices of the UC San Diego Faculty and providers. He serves on the Executive Governing Board of UC San Diego Health Sciences and the Executive Committee of UCSD’s Clinical Integration Network.

Dr. Kane is an internationally recognized expert in prostate cancer and kidney cancer epidemiology, risk stratification and outcomes after treatment. He completed his urology residency at Oakland Naval Hospital and UC San Francisco. He earned his medical degree at Uniformed Services University and his BS degree in mechanical engineering at UC Davis. Kane served as the Urology residency director at the Naval Medical Center in San Diego from 1995-2001. He was also the Surgeon General’s Advisor for Urology from 1998-2001. Dr. Kane then joined the faculty at UCSF, where he was Division Chief at the VAMC from 2001-2007. He joined UCSD as Division Chief and Urology Program Director in 2007. Urology became a clinical department in 2013 and became a new academic department at UCSD in 2017 with Kane as the Founding Chair. He also served as Interim Chair of the Department of Surgery from 2013-2015 and Senior Associate Director of Cancer Surgery from 2016-2018.

He was Co-Chair of the Renal Cell Carcinoma Advisory Task Force, National Cancer Institute from 2009-2016. He is on the NCCN treatment guidelines in prostate cancer committee. He was elected to the American Association of GU Surgeons in 2014 and to the Clinical Society of GU Surgeons in 2017. He was selected as a “Top Doctor” in San Diego in 2008-2019 and was selected as one of two Physician Healthcare Champions for 2010 in San Diego by the San Diego Business Journal. He was awarded the Distinguished Engineering Alumni Medal by UC Davis in 2011. He is a retired Navy Captain and a decorated veteran of Desert Storm. Dr. Kane has authored more than 360 publications and book chapters, primarily on prostate cancer risk factors and outcomes, prostate cancer surgery, and minimally invasive surgery for prostate and kidney cancer.

Kathleen C. Kobashi, MD

Kathleen C. Kobashi, MD

TRUSTEE

Kathleen Kobashi is Chief of the Department of Urology at Houston Methodist Hospital in Texas.  Prior to this, she served as Section Head of Urology and Renal Transplantation at Virginia Mason Medical Center for 14 years and Director of VM’s Pelvic Floor Center. She received her B.A. at Wellesley College and her M.D. at Hahnemann University in Philadelphia, and completed her urologic residency at the University of California, Irvine followed by a Female Pelvic Medicine and Reconstructive Surgery (FPMRS) fellowship at Cedars-Sinai in Los Angeles before joining Virginia Mason in 1999.  She is currently pursuing her Executive MBA at the University of Michigan.

In addition to her passion around clinical medicine, Dr. Kobashi is dedicated to research and education of patients and future urologists. She is a mentor for the AUA Leadership program, and she founded the VM FPMRS fellowship in 2003 and a new Urology residency in 2014, for which she served as the Program Director.  Dr. Kobashi has authored more than 100 peer-reviewed articles and book chapters on topics related to urinary incontinence and pelvic prolapse and has been invited faculty on the subject around the globe. She is the Immediate Past President of SUFU (Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction), the Immediate Past President (first female) of the Western Section AUA and will begin her term as a Trustee of the American Board of Urology in 2022.  She is the Associate Editor of Urology Practice, and the Societe Internationale d’Urologie Journal. She received the 2006 Continence Care Champion award from the National Association for Continence, the prestigious Paul Zimskind Award from SUFU in 2010, and a Presidential Citation from the American Urological Association in 2013.

Cheryl T. Lee, MD

Cheryl T. Lee, MD

TRUSTEE

Dr. Lee is Professor and Chair of the Department of Urology at The Ohio State University Wexner Medical Center where she holds the Dorothy M. Davis Endowed Chair in Cancer Research. She is also the Vice President of the OSU Physicians and Faculty Group Practice.

She obtained her undergraduate degree from Rensselaer Polytechnic Institute and her medical training at the Albany Medical College. She completed her Urology residency at the University of Michigan and her fellowship in Urologic Oncology at the Memorial Sloan Kettering Cancer Center. She was a member of the faculty at the University of Michigan for 16 years, during which time she served as Fellowship Director in Urologic Oncology, was the Director of the Office of Continuous Professional Development within the College of Medicine, and was the inaugural holder of the Dr. Robert H. and Eva M. Moyad Research Professorship. She moved to OSU in 2016.

Her medical professional focus is dedicated to improving the care of bladder cancer patients through advocacy, education and research. She has served the Bladder Cancer Advocacy Network as the President of the Scientific Advisory Board and a current member of its Board of Directors. She is a past-member of the SUO Board of Directors and currently serves as its liaison to the AJCC. She also previously served on the Board of Directors of the American Cancer Society, Lakeshore Division, and the National Medical Association. Throughout her career, she has worked to improve the surgical outcomes for bladder cancer patients through interdisciplinary research, clinical trials, and outcome studies.

Dr. Lee is active in the education of students, residents, and practicing urologists. She has supported educational initiatives through her roles on the AUA Education Council, AUA Science and Quality Council, and the AUA Update Editorial Board. She has played a key role in the board certification of urologists in America through her service on the ABU/AUA Examination Committee, the ABU Oral Board Examination Committee, and the Oncology Knowledge Assessment Test Committee of the SUO.

Dr. Lee is originally from New York, though has lived in the Midwest for most of her adult life. She is married to William (Bill) Amato, and has two children, Jackson and Ashton.

David B. Joseph, MD

David B. Joseph, MD

LLL CHAIR

Dr. Joseph is a native of Wisconsin and has an undergraduate degree from Johns Hopkins University. He completed medical school training at the University of Wisconsin and continued with urology residency at the University of Wisconsin. He went on to fellowship training in pediatric urology at Boston Children’s Hospital/Harvard Medical School.

Dr. Joseph is currently Professor of Urology within the Department of Urology at the University of Alabama at Birmingham. He is Chief of Pediatric Urology at Children’s of Alabama and holds the Beverly P. Head endowed chair in pediatric urology. Dr. Joseph has a special interest in pediatric neurourology and is a member of the Board of Directors of the Spina Bifida Association.

Dr. Joseph is a member of several organizations including a Fellow of the American College of Surgeons, a Fellow of the American Academy of Pediatrics and a past President of the Society for Pediatric Urology. Dr. Joseph has served on the ABU/AUA Joint Examination Committee as a member, consultant and past chair. He became a Diplomate of the ABU in 1987, recertified in 1995, 2005 and added Subspecialty Certification in Pediatrics in 2008.

J. Brantley Thrasher, MD

J. Brantley Thrasher, MD

EXECUTIVE DIRECTOR

Dr. J. Brantley Thrasher is the William L. Valk Distinguished Professor and former chair of the Department of Urology and the Co-Director of Operative Services at the University of Kansas Medical Center in Kansas City, Kansas. A native of South Carolina, he completed his Medical Degree at the Medical University of South Carolina in Charleston, South Carolina, an internship at Walter Reed Army Medical Center in Washington D.C., and his urology residency at Fitzsimons Army Medical Center in Aurora, Colorado. He subsequently completed a urologic oncology fellowship at Duke University Medical Center. He served for three years as Program Director for the Urology Residency Program at Madigan Army Medical Center in Tacoma, Washington, and after completing his military obligation, he was appointed as Chair in 1998.

He is immediate Past-President of the American Urological Association (AUA), Past-President of the Society of Urology Chairpersons and Program Directors, Past-President of the Society of Urologic Oncology, and a previous member of the Residency Review Committee for Urology. He has served as the Vice-President of the American Board of Urology and as the South Central Section Representative to the AUA Board of Directors. He is a Diplomat of the American Board of Urology, a Fellow of the American College of Surgeons, a member of the American Association of Genitourinary Surgeons, and a member of the Clinical Society of Genitourinary Surgeons. He was awarded the Distinguished Service Award from the AUA in 2015, for 15 years of service to academic and organized urology, and was also awarded the Distinguished Service award from the Society of Urologic Oncology (SUO), in 2017. He stepped down as Chair of the Department of Urology in June 2016, in order to dedicate more time to his position and service for the AUA. He is currently Executive Director of the American Board of Urology.

Dr. Thrasher has served on numerous national committees, including the American Joint Committee on Cancer (AJCC), as the Kansas State Representative to the Board of Directors of the South Central Section of the American Urological Association (AUA), as the Chair of the Fellowship Committee for the Society of Urologic Oncology, and as a member of the American College of Radiology Expert Advisory Panel on Prostate Cancer. He has served as Chairman of the Metropolitan Kansas City Committee on fellowship applicants for the American College of Surgeons, President of the South Central Section of the AUA, the South Central Section representative of the AUA Board of Directors, and the South Central Section Health Policy Committee. He was previously the Chair of the Public Media, Practice Guidelines and Prostate Cancer Guidelines (vice-chair) Committees, a mentor for the AUA Leadership Program, a member of the Best Practice Policy Panel on Cryotherapy for the Treatment of Prostate Cancer, the Chair of the Prostate Cancer Literature Review Panel and the Audio-Visual Committee of the AUA.

In addition to giving over 400 presentations at local, national, and international meetings, he has written over 200 manuscripts, book chapters, and monographs in the field of urology. He currently serves as Coordinating Editor for Practical Reviews in Urology, an Associate Editor for the book, “The 5-Minute Urology Consult;” and as an Editorial Consultant for Urology Times.

ABU Logo

HONOR A MENTOR, COLLEAGUE, OR ANOTHER PERSON

MAKE A DONATION TODAY

©2022 The American Board of Urology  |  All Rights Reserved  |  Site by Blue Cloud Studio

Search